Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study.
Khodaie F, Moghadasi AN, Hosseinnataj A, Baghbanian SM, Ashtari F, Razazian N, Poursadeghfard M, Majdi-Nasab N, Hatamian H, Hoseini S, Nahayati MA, Nabavi SM, Faraji F, Harirchian MH, Mir NHN, Moghadam NB, Sharifipour E, Bayati A, Kamali H, Mozhdehipanah H, Jalali N, Abotorabi-Zarchi M, Kamyari N, Nikbakht R, Azimi A, Navardi S, Heidari H, Sahraian MA, Eskandarieh S. Khodaie F, et al. Among authors: moghadam nb. Clin Neurol Neurosurg. 2024 Apr;239:108221. doi: 10.1016/j.clineuro.2024.108221. Epub 2024 Mar 2. Clin Neurol Neurosurg. 2024. PMID: 38447483
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Togha M, Karvigh SA, Nabavi M, Moghadam NB, Harirchian MH, Sahraian MA, Enzevaei A, Nourian A, Ghanaati H, Firouznia K, Jannati A, Shekiba M. Togha M, et al. Among authors: moghadam nb. Mult Scler. 2010 Jul;16(7):848-54. doi: 10.1177/1352458510369147. Epub 2010 May 20. Mult Scler. 2010. PMID: 20488825 Clinical Trial.
Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.
Bonab MM, Sahraian MA, Aghsaie A, Karvigh SA, Hosseinian SM, Nikbin B, Lotfi J, Khorramnia S, Motamed MR, Togha M, Harirchian MH, Moghadam NB, Alikhani K, Yadegari S, Jafarian S, Gheini MR. Bonab MM, et al. Among authors: moghadam nb. Curr Stem Cell Res Ther. 2012 Nov;7(6):407-14. doi: 10.2174/157488812804484648. Curr Stem Cell Res Ther. 2012. PMID: 23061813 Clinical Trial.
Iranian consensus on use of vitamin D in patients with multiple sclerosis.
Jahromi SR, Sahraian MA, Togha M, Sedighi B, Shayegannejad V, Nickseresht A, Nafissi S, Mohebbi N, Majdinasab N, Foroughipour M, Etemadifar M, Moghadam NB, Ayramlou H, Ashtari F, Alaie S. Jahromi SR, et al. Among authors: moghadam nb. BMC Neurol. 2016 May 21;16:76. doi: 10.1186/s12883-016-0586-3. BMC Neurol. 2016. PMID: 27209163 Free PMC article. Review.
Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.
Sahraian MA, Moghadasi AN, Azimi AR, Asgari N, H Akhoundi F, Abolfazli R, Alaie S, Ashtari F, Ayromlou H, Baghbanian SM, Moghadam NB, Fatehi F, Foroughipour M, Langroodi HG, Majdinasab N, Nickseresht A, Nourian A, Shaygannejad V, Torabi HR. Sahraian MA, et al. Among authors: moghadam nb. Mult Scler Relat Disord. 2017 Nov;18:144-151. doi: 10.1016/j.msard.2017.09.015. Epub 2017 Sep 25. Mult Scler Relat Disord. 2017. PMID: 29141797 Review.
Primary progressive multiple sclerosis in Iran: A consensus recommendation for diagnosis and management.
Sahraian MA, Baghbanian SM, Langroodi HG, Abolfazli R, Alaie S, Asgari N, Ashtari F, Ayromlouh H, Moghadam NB, Foroughipour M, Majdinasab N, Mohammadianinejad SE, Nickseresht A, Nourian A, Shahmohammadi S, Shayegannejad V, Torabi HR. Sahraian MA, et al. Among authors: moghadam nb. Mult Scler Relat Disord. 2018 Nov;26:112-120. doi: 10.1016/j.msard.2018.09.013. Epub 2018 Sep 12. Mult Scler Relat Disord. 2018. PMID: 30245383 Review. No abstract available.
Antigliadin antibody in sporadic adult ataxia.
Hamidian Y, Togha M, Nafisi S, Dowlatshahi S, Jahromi SR, Moghadam NB, Namazi N, Tajik P, Majed M, Aloosh M. Hamidian Y, et al. Among authors: moghadam nb. Iran J Neurol. 2012;11(1):16-20. Iran J Neurol. 2012. PMID: 24250853 Free PMC article.
A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
Najafi S, Moghadam NB, Saadat P, Noorbakhsh SM, Mohammadi AV, Manouchehrinia A, Hosseini M, Matsuo H, Mirshafiey A. Najafi S, et al. Among authors: moghadam nb. Int J Neurosci. 2022 Apr;132(4):403-412. doi: 10.1080/00207454.2020.1818741. Epub 2020 Sep 7. Int J Neurosci. 2022. PMID: 32878514 Clinical Trial.
24 results